View Cart (0 items)

Pharmaceutical

Banned drugs found in dietary supplements after recalls

New research suggests that more rigorous regulatory oversight is needed in the dietary supplements industry.
Read More

Bayer Healthcare closes Dihon acquisition, invests in Versant fund

Bayer HealthCare, part of German chemical and pharmaceutical group Bayer AG, has completed its acquisition of Chinese pharmaceutical company Dihon Pharmaceutical Group Co., Ltd.
Read More

GlaxoSmithKline plans stock market sale of minority stake in HIV treatment company

British pharmaceutical group GlaxoSmithKline plc (GSK) is planning to spin off a subsidiary that focuses on developing treatments for HIV.
Read More

Novartis to sell influenza vaccines business for $275 million

Healthcare company Novartis has entered into an agreement to sell its influenza vaccines unit for $275 million.
Read More

PACK EXPO 2014 expected to set attendance records

PMMI, the Association for Packaging and Processing Technologies, predicts 2014 will set some new records for PACK EXPO International and the debut of Pharma EXPO.
Read More

Three Nigerian pharmaceutical firms get WHO certification

Three pharmaceutical manufacturers in Nigeria have been certified by the World Health Organization (WHO) to produce drugs in accordance with its Good Manufacturing Practice (GMP).
Read More

Auxilium Pharmaceuticals agrees to acquisition deal with Endo

Specialty biopharmaceutical company Auxilium Pharmaceuticals, Inc. is to be acquired by Endo International plc for $2.6 billion, including the repayment and assumption of debt.
Read More

Teva to end cancer, women's health research

Generic drugmaker Teva Pharmaceutical Industries Ltd. has decided to stop research and development in a number of areas, including oncology and women's health, as part of efforts to cut costs.
Read More

Antibiotics, heavy metals in the environment contribute to resistance

Very low concentrations of antibiotics and heavy metals in the environment contribute to antibiotic resistance, a new Swedish study has demonstrated.
Read More

Consort agrees to $372 million acquisition of Aesica

U.K.-based healthcare company Consort Medical plc announced on Tuesday an agreement to acquire Aesica Pharmaceuticals.
Read More